Q2 2026 earnings call recap: 17% core revenue growth, 18% margin, raised FY26 guidance, AI fraud wins, and Q3 outlook—read key takeaways.

BILL stock jumps 30% on report Hellman & Friedman is in talks to buy Bill Holdings after strong Q2 FY2026 results and guidance.

Rejuvant’s CaAKG Supplement Becomes Core Requirement in Lionheart’s KLOTHO-UP™ Study and Klotho Wellness Program ...

BILL Holdings (BILL) shares jumped 14% in Friday morning trading after the small-business-focused financial operations ...

Dietary supplements are not approved for safety or efficacy by the U.S. Food and Drug Administration (FDA), and ingredients ...

Ditch the exhausting marathons and reclaim your midsection with a professional-grade circuit designed to activate deep ...

Detailed price information for Denali Therapeutics Inc (DNLI-Q) from The Globe and Mail including charting and trades.

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR"), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today announced the presentation of four ...

Cognizant’s BPO business is expected to grow for decades despite the rise of AI because of need to modernize legacy processes and operations, Kumar said.

A report from UK Active and Les Mills has found that 43 per cent of adults are failing to meet the Chief Medical Officer’s ...

Pacific Carriers, Okami HD, Hotline Miami, Dragon's Crown, Assassin's Creed IV: Black Flag, Need for Speed Rivals, LEGO Marvel Super Heroes and more ...

From keepsakes to indulgences, explore refined Valentine’s Day gifts that celebrate love with style, intention and timeless ...